Jeff Shrager, PhD Co-Founder and Director of Research at xCures, Adjunct Professor of the Symbolic Systems Program at Stanford University, and former Director of Research at Cancer Commons
-
April 27, 2020
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
With: Jeff Shrager, PhDRazelle Kurzrock, MDIn a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. Here, AI expert Jeff Shrager, PhD, responds, and Kurzrock offers a rebuttal. Shrager is Co-Founder and Director of Research at xCures, and was formerly Director of Research at Cancer Commons. He is also an… Read more »
-
August 6, 2018
Q&A: Air Traffic Control for Cancer
With: Jeff Shrager, PhDA Q&A with David K. Cundiff, MD, Retired internist and palliative care physician from LA County + USC Medical Center; Email: dkcundiff@whistleblowerdoctor.org. Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, Stanford University; Email: jshrager@gmail.com. Originally published August 16, 2017 Q: After May 17, 2017, you and Jeff Shrager engaged in a robust discussion about the place, if any, for an “Air… Read more »
-
July 30, 2018
Forget Moonshots: Biomedicine Needs an Air Traffic Control System
With: Jeff Shrager, PhDA Q&A with Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct Professor, Symbolic Systems Program, Stanford University Originally published May 17, 2017 Q: There never seem to be enough patients matched to cancer clinical trials to quickly test new cancer treatments. Might there be a better way, using new communication technology? A: Among the few things that everyone can agree upon, one is… Read more »